Abstract

PreScription: Compounded Drugs Often Become Manufactured Drugs

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 444

Download in electronic PDF format for $75
  • PreScription: Compounded Drugs Often Become Manufactured Drugs Page 1

Abstract

Related Keywords

  • compounded preparations
  • manufactured preparations
  • new drug approvals 2022

Related Categories

  • HISTORY
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2022
Pg. 444
PreScription: Compounded Drugs Often Become Manufactured Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 4
PreScription: New Drug Approvals 2022 and Compounding Opportunities
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 292-293
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 101-111
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Author(s): Timko Robert J, Crooker Philip EM
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Sep/Oct 2013
Pg. 356
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2003
Pg. 21-23
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Author(s): Vail Jane
Jul/Aug 2002
Pg. 271-273
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Author(s): Kramer Mark A, Grilley Bambi J
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
May/Jun 2013
Pg. 180
PreScription: Compounding for Drug Shortages
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 307-311
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Author(s): McElhiney Linda F
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 358-364
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Author(s): Palma Elisabetta, Bufarini Celestino